Citation Tools

Extended report
Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis

Download to a citation manager

Cite this article as:
Takeuchi T, Miyasaka N, Tatsuki Y, et al
Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis